fbpx
  1. Home
  2. »
  3. Pandemic Pulse
  4. »
  5. Daily News Pulse
  6. »
  7. Daily News Pulse for January 15, 2023

Daily News Pulse for January 15, 2023

Facebook
Twitter
LinkedIn
Print
Summary: The WHO has asked China to continue releasing information about its COVID-19 cases after the government reported nearly 60,000 deaths since December. A large study conducted in Israel found that most long COVID symptoms resolve within the first year after infection for people with mild cases of COVID-19.
  • WHO appeals to China to release more COVID-19 information – KCRA Sacramento: The WHO has asked China to continue releasing information about its COVID-19 cases after the government reported nearly 60,000 deaths since December. The US, South Korea and others have imposed travel restrictions due to the lack of information. The government reported 5,503 deaths from respiratory failure caused by COVID-19 and 54,435 fatalities from other causes.
  • WHO welcomes data on COVID-19 in China, meeting with Minister – World Health Organization: WHO Director-General Dr Tedros Adhanom Ghebreyesus spoke with Minister Ma Xiaowei, director of China’s National Health Commission, about the COVID-19 situation in the country. Chinese officials provided information to WHO and in a press conference on a range of topics, including outpatient clinics, hospitalizations, patients requiring emergency treatment and critical care, and hospital deaths related to COVID-19 infection. WHO is analysing this information to gain a better understanding of the epidemiological situation and the impact of this wave in China.
  • Long COVID patients in N.L. say they’re tired of suffering in the dark – CBC.ca: Dara Barrett of St. John’s contracted COVID-19 in early February 2022 and has been suffering from long COVID symptoms since then, including exhaustion and joint pain. She has not been able to work since June and was recently approved for long-term disability benefits. Long COVID is a condition in which a cluster of symptoms persist for weeks or months after the initial infection.
  • Most long-term symptoms from mild COVID resolve within year, study says, but some experts disagree – KMBC Kansas City: A large study conducted in Israel found that most long COVID symptoms resolve within the first year after infection for people with mild cases of COVID-19. The study provides reassurance that mild disease does not lead to serious or chronic long term morbidity in the vast majority of patients.
  • Thousands of Philadelphians must resume applying annually for Medicaid starting in April – The Philadelphia Inquirer: Aisha Ahmad, a resident of West Philadelphia, has kept her Medicaid insurance during the pandemic due to a rule that prohibited states from ending coverage. However, this rule is set to expire in April, meaning Ahmad and hundreds of thousands of other Pennsylvanians must reapply or risk losing coverage.
  • Why Remote Working Isn’t Always The Answer For Employees With Disabilities – Forbes: The Covid-19 pandemic has led to an increase in remote working, which has been beneficial for those with disabilities. This is due to the removal of access barriers such as inaccessible public transportation, physical and psychological stress, and lack of workplace accommodations. This trend is expected to continue into 2022, with people with disabilities being 3.5% more likely to be employed than pre-pandemic.
  • What do we know about new COVID variant XBB.1.5? – Al Jazeera English: The Omicron XBB.1.5 variant is spreading rapidly across dozens of countries, causing concern among scientists. It is now the second-most dominant strain in the US and is also rising in parts of Europe. Other Omicron variants have been linked to a sharp increase in COVID-19 cases in China.
  • Lincoln health department monitoring new Covid variant – KLKN: The Lincoln-Lancaster County Health Department is monitoring the new Covid-19 variant XBB.1.5, which is more contagious than previous strains. Bivalent boosters offer some protection against it. The Covid risk dial is currently at yellow, and cases and hospitalizations have decreased from last week. The CDC has approved boosters for children under 12.
  • Omicron subvariant XBB.1.5 possibly more likely to infect those who … – 1330 WFIN: New York City health officials are warning residents that the infectious omicron subvariant XBB.1.5 may be more likely to infect people who have already been vaccinated or infected with COVID-19. Vaccination is still the best way to protect against hospitalization and death, including from new variants.

Daily News Pulse for January 29, 2023

Summary: Governor John Carney has tested positive for COVID-19 and is working from home. The 7-day average of new cases in Delaware is 135, with 158 hospitalizations. A new study has found that 71% of people with long COVID required medical treatment or were unable to work for six months or more. The FDA has withdrawn emergency use authorization for the COVID-19 antibody drug Evusheld due to its ineffectiveness against the Omicron variants now dominating the US.

Daily Research Pulse for January 29, 2023

Summary: One study analyzed the frequency of influenza and SARS-CoV-2 co-infections, as well as the differences in the course of disease in patients infected with the SARS-CoV-2 virus in relation to flu vaccination status in a cohort of 19,850 patients diagnosed with COVID-19 in Spain.

Daily News Pulse for January 28, 2023

Summary: Scientists have found that 36% of students and faculty at George Washington University have a history of COVID-19 reported symptoms consistent with long COVID. Vaccinations may be linked to lower post-COVID-19 risk factors, but more research is needed. A new study from INSPIRE found that half of COVID-positive patients and one-quarter of those who tested negative had at least one symptom at three months follow-up.

Daily Research Pulse for January 28, 2023

Summary: One study examined the impact of COVID-19 on access to general practice care in Ireland by conducting an online survey of 670 adult patients of Irish general practices. Another study looked at the effectiveness of the mRNA COVID-19 vaccine among urban underserved Hispanic/Latino populations.

Daily News Pulse for January 27, 2023

Summary: The FDA has voted to update all Covid-19 vaccines to contain the same ingredients as the two-strain shots used as booster doses. Studies have shown that the SARS-CoV-2 spike protein can cross the blood-brain barrier, leading to cognitive impairment and inflammation. CDC data shows that COVID cases, deaths, and hospitalizations have stabilized after a small surge around the holidays, but there is still uncertainty about long COVID.